NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)

Go to Funding Search

Key Information

Due Date: May 7, 2024


Agency: U.S. Department of Health and Human Services (HHS)


Source: Federal


Funding Category:

Health & Human Services

Funding Amount: $581,371


Funding Type: Cooperative Agreement


Match Required: No


Contact Info: grantsinfo@nih.gov
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Overview

The National Institute of Neurological Disorders and Stroke (NINDS) has announced a Funding Opportunity, known as the NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required). The intention of this grant is to invite applications from investigators who wish to carry out efficacy clinical trials. These proposed trials must be in accordance with the mission and research interests of the NINDS.

The scope of these trials may cover a variety of areas. This could include evaluation of drugs, biologics, and medical devices. Additionally, surgical procedures, behavioral strategies, and rehabilitation therapies could also be covered under this grant.

Interested applicants can familiarize themselves with the mission and research interests of the NINDS by visiting their official website at http://www.ninds.nih.gov/. This is an excellent opportunity to contribute to the field of neurological disorders and stroke research.

Show More

Key Dates

Open Date: May 19, 2021


Application Due Date: May 7, 2024


Estimated Award Date: Not Specified

Additional Details

Eligible Activities

  • Research and Development

Eligible Applicants

  • State governments
  • County governments
  • City, village or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Private institutions of higher education
  • Small businesses

Search MI Funding Hub

NOTE: Site search does not include grant search. See Find Funding page for grant searching.